Shanghai:688222

HitGen has successfully completed a three-year collaboration with MTPC to discover novel hit compounds for multiple drug targets

CHENGDU, China, Feb. 24, 2022 /PRNewswire/ -- HitGen Inc. ("HitGen"), a Shanghai Stock Exchange STAR-listed company, today announced that the company has successfully completed a three-year drug discovery research collaboration with Mitsubishi Tanabe Pharma Corporation ("MTPC"), a Japanese pharma...

2022-02-25 10:00 2192
12